Zacks Research Weighs in on Chemours’ Q1 Earnings (NYSE:CC)

The Chemours Company (NYSE:CC) – Equities researchers at Zacks Research lowered their Q1 2026 earnings per share estimates for Chemours in a research report issued on Wednesday, March 4th. Zacks Research analyst Team now forecasts that the specialty chemicals company will earn ($0.09) per share for the quarter, down from their prior estimate of $0.20. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q4 2026 earnings at $0.13 EPS, FY2026 earnings at $1.06 EPS, Q3 2027 earnings at $0.52 EPS and FY2027 earnings at $1.97 EPS.

Chemours (NYSE:CC) last announced its quarterly earnings data on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period last year, the firm earned $0.09 EPS. The company’s revenue was down 2.2% on a year-over-year basis.

A number of other research firms have also recently commented on CC. Mizuho lifted their price target on shares of Chemours from $17.00 to $21.00 and gave the stock an “outperform” rating in a research note on Thursday, March 5th. The Goldman Sachs Group increased their target price on shares of Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a report on Wednesday, February 25th. Morgan Stanley raised their price objective on Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a research report on Monday, February 23rd. JPMorgan Chase & Co. upped their price target on Chemours from $13.00 to $17.00 and gave the stock a “neutral” rating in a research report on Monday, February 23rd. Finally, Jefferies Financial Group reissued a “hold” rating and set a $17.00 target price on shares of Chemours in a research report on Monday, February 23rd. Five research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Chemours presently has an average rating of “Hold” and a consensus target price of $18.40.

Chemours Trading Up 2.0%

CC stock opened at $17.76 on Monday. The firm has a fifty day moving average price of $16.60 and a 200 day moving average price of $14.78. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.85 and a current ratio of 1.78. The firm has a market cap of $2.67 billion, a PE ratio of -7.16 and a beta of 1.60. Chemours has a fifty-two week low of $9.13 and a fifty-two week high of $21.85.

Hedge Funds Weigh In On Chemours

A number of hedge funds have recently bought and sold shares of the business. Atlas Capital Advisors Inc. acquired a new stake in shares of Chemours in the fourth quarter valued at about $26,000. MTM Investment Management LLC acquired a new stake in shares of Chemours during the 2nd quarter worth about $27,000. Aster Capital Management DIFC Ltd purchased a new stake in Chemours in the fourth quarter valued at approximately $28,000. Covestor Ltd increased its stake in Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after buying an additional 1,748 shares during the period. Finally, Eurizon Capital SGR S.p.A. purchased a new position in shares of Chemours in the 4th quarter valued at about $31,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 27th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, February 27th. Chemours’s payout ratio is currently -14.11%.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.